A recent study found that a selection of non-invasive markers could help identify high-risk children with pulmonary arterial hypertension associated with congenital heart disease. Pulmonary arterial ...

A recent study sought to examine the course of these patients after the age of 40, and to identify possible risk factors for a worse prognosis. There has been an increase in life expectancy for ...

We previously reported on the partial prevention of experimental shunt-induced pulmonary arterial hypertension (PAH) by the nonselective endothelin (ET) ET-A/ET-B receptor antagonist bosentan. As the ...

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of ...

Please provide your email address to receive an email when new articles are posted on . Cytokine profiles can distinguish patients with systemic sclerosis who are at high risk for, or have, pulmonary ...